ERA-CVD Joint Transnational Call 2018
|
Project: Investigating DETerminants of atrial Electrical ConducTion underlying ARRHYTHMIAS
Call: Transnational Cardiovascular Research Projects driven by Early Career Scientists Partners: Research partners are from Germany, Italy, Turkey, and Estonia. |
Budget
797,900 € |
Gilead Sciences International Research Scholars Program in Hematology/Oncology
|
Dr. Kocabas has been awarded with Gilead Sciences International Research Scholars Program in Hematology/Oncology. Study will involve development of small molecule MEIS inhibitors for mitigating cancer growth.
Award recipients |
Budget
130,000 USD |
2018 Gilead ile Hayat Bulan Fikirler Programı
|
Gilead ile Hayat Bulan Fikirler Programı’na yapmış olduğumuz, “Lösemi kök hücrelerinde MEIS ekspresyon profilinin belirlenmesi ve MEIS inhibitörlerinin
etkisinin incelenmesi” başlıklı projemiz; değerlendirme kurulu tarafından değerlendirilerek 74.000 TL katkı almaya hak kazanmıştır. Our project titled "Determining the MEIS expression profile in leukemia stem cells and examining the effect of MEIS inhibitors in LSCs" was evaluated by the evaluation board and received TL 74.000 contribution by Gilead ile Hayat Bulan Fikirler Program. |
Budget
74,000 TL |
TUBİTAK - ARDEB 1001 Program
|
July 2015 - Dr. Kocabas awarded by TÜBİTAK ARDEB 1001 Program
Dr. Kocabas was awarded withın ARDEB 1001 Program by TÜBİTAK to conduct his research on the molecular mechanism of heart regeneration. Successful completion of this study will allow understanding of molecular pathways involved in heart regeneration and provide tools to address prospect of heart regeneration. Award includes over 360, 000 TL to be used towards equipment, consumables and scholarship for graduate students in two and half years |
Budget
541.500 TL |
ICGEB - CRP Research Grants Programme 2015
|
September 2015- Dr. Kocabas was awarded by ICGEB - CRP Research Grants Programme 2015.
Dr. Kocabas`s application titled "Development of Hematopoietic Stem Cell Expansion Technologies" to The International Centre for Genetic Engineering and Biotechnology - Early Career Return Grant application has been approved. Successful completion of this study will allow development of novel tools to expand HSCs ex vivo. |
Budget
54,000 Euros 237.600 TL (1 Euro=4.4 TL) |
TÜBİTAK - ARDEB 3501 Program
January 2016 - Dr. Kocabas awarded TUBITAK ARDEB 3501 Career Development Funding
The Scientific and Technological Research Council of Turkey (TÜBİTAK) has awarded Dr. Kocabas within Career Development Program to conduct his research on development of cardiogenic inhibitors that will induce cardiomyocyte proliferation in vitro. Successful completion of this project will provide a platform to develop therapeutical approaches towards induction of cardiac repair in vivo. Award includes a total of 340000 TL to be used towards equipment and consumable purchases, travel, and scholarships in two years. |
Budget
340.350 TL |
TÜBİTAK - ARDEB 1001 Program
January 2016 - Dr. Kocabas awarded by TÜBİTAK ARDEB 1001 Program
Dr. Kocabas was awarded withın ARDEB 1001 Program by TÜBİTAK to conduct his research on Characterization of viral OTU-like novel parasite proteins. Successful completion of this study will allow understanding of molecular mechanisms involved in malaria progression and provide tools to identify new molecular targets. Award includes over 420.300 TL to be used towards equipment, consumables and scholarship for graduate students in two and half years |
Budget
420.300 TL |
Turkish Society of Hematology (Türk Hematoloji Derneği) Research Award
|
Turkish Society of Hematology (Türk Hematoloji Derneği) awarded Yeditepe University Regenerative Biology Research Lab to pursue studies on ex vivo HSC expansion and identification of novel small molecule inhibitors. Award includes 30, 000 TL to be used towards consumables in one and half years.
|
Budget
30.000 TL |
TÜBİTAK - ARDEB 1002 Program
June 2017- Dr. Kocabas was awarded within ARDEB 1002 Programs by TÜBİTAK. Awards includes 30, 000 TL to be used towards consumables and scholarship for graduate students in six months. Project involves investigating small molecules targeting cellular quiescence in fibroblast expansion and IPSC gene activation,
|
Budget
30.000 TL |
Other Funds
|
PhD Scholarship from TÜBİTAK-BİDEB 2211- A Program (Esra Albayrak)
120.000 TL for 5 years 2209A Undergrad Research Support to:
|
Budget
135.000 TL |
CO-FUNDED Brain Circulation Scheme (The Marie Curie Action Cofund & TÜBİTAK)
|
February 2015 - Dr. Kocabas awarded by CO-FUNDED Brain Circulation Scheme (The Marie Curie Action Cofund & TÜBİTAK)
Dr. Kocabas was awarded within Co-Funding Scheme supported by TÜBİTAK and The Marie Curie Action COFUND, of the 7th. Framework Programme (FP7) of the European Commission to conduct his research on ex vivo stem cell expansion procedures. Successful completion of this project will provide a platform to develop therapeutical approaches towards expansion of hematopoeitic stem cells ex vivo. Award includes a total of 114,000 Euros to be used towards scholarship, travel and consumables in two years. |
Budget
323. 160 TL |
BAGEP - Science Academy, Turkey
May 2015 - Science Academy awarded Dr. Kocabas with Young Scientist Award. Award includes research support as well that will be used towards travel and consumables in two years.
|
Budget
20.000 TL |
Yeditepe University Startup Funding
August 2014 - Dr. Kocabas was supported by Yeditepe University, Department of Genetics and Bioengineering to establish Regenerative Biology Research Laboratory.Support will be used towards equipment and consumables in two years.
|
Budget
150.000 TL |
|
June 2014 - Dr. Kocabas awarded TUBITAK BIDEB 2232 Funding
The Scientific and Technological Research Council of Turkey (TÜBİTAK) has awarded Dr. Kocabas within 2232 Program. Award included a total of 100,000 TL to be used towards equipment and consumable purchases, travel, and scholarships in two years. |
Budget
108.000 TL |
|
|
|